Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burnham, C.-A. D.
Right arrow Articles by Tyrrell, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burnham, C.-A. D.
Right arrow Articles by Tyrrell, G. J.
Agricola
Right arrow Articles by Burnham, C.-A. D.
Right arrow Articles by Tyrrell, G. J.
Microbiology 153 (2007), 4240-4252; DOI  10.1099/mic.0.2007/008417-0
© 2007 Society for General Microbiology

Invasion of HeLa cells by group B streptococcus requires the phosphoinositide-3-kinase signalling pathway and modulates phosphorylation of host-cell Akt and glycogen synthase kinase-3

Carey-Ann D. Burnham1, Sandra E. Shokoples2 and Gregory J. Tyrrell1,2,3

1 The Department of Laboratory Medicine and Pathology, The University of Alberta, Edmonton, AB, Canada
2 The National Centre for Streptococcus, The Provincial Laboratory for Public Health (Microbiology), Edmonton, AB, Canada
3 The Department of Medical Microbiology and Immunology, The University of Alberta, Edmonton, AB, Canada

Correspondence
Gregory J. Tyrrell
g.tyrrell{at}provlab.ab.ca

The group B streptococcus (GBS) is an opportunistic bacterial pathogen with the ability to cause invasive disease. While the ability of GBS to invade a number of host-cell types has been clearly demonstrated, the invasion process is not well understood at the molecular level. What has been well established is that modulation of host-cell actin microfilaments is essential for GBS invasion to occur. Phosphoinositide-3 kinase (PI3K) is a key regulator of the cytoskeleton in eukaryotic cells. Our goal in this investigation was to explore the role of the PI3K/Akt signalling pathway in epithelial cell invasion by GBS. The epithelial cell invasion process was mimicked using the HeLa 229 cell-culture model. Treating HeLa cells with chemical inhibitors of PI3K, Akt or Ras prior to bacterial infection inhibited GBS invasion but not attachment; treatment with 30 µM LY294002 (PI3K inhibitor) reduced GBS invasion by 75 %, 20 µM L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate (ICIO) (Akt inhibitor) reduced GBS invasion by 50 %, and 10 µM manumycin A (Ras inhibitor) inhibited GBS invasion by 90 %. Genetic inactivation of the p85{alpha} or p110{alpha} PI3K subunits in HeLa cells also reduced GBS invasion by 55 and 30 %, respectively. Western blot analysis revealed that phosphorylation of host-cell Akt and glycogen synthase kinase-3 (GSK-3) occurs in response to GBS infection, and that this is mediated upstream by PI3K. Infection of HeLa cells with GBS triggers pro-survival signalling and protects the HeLa cells from camptothecin-induced caspase-3 cleavage. The results from this investigation show that GBS both requires and activates the PI3K/Akt host-cell signalling pathway during invasion of epithelial cells.


Abbreviations: CPT, camptothecin; GAS, group A streptococcus/streptococci; GBS, group B streptococcus/streptococci; GSK-3, glycogen synthase kinase-3; HK-GBS, heat-killed GBS; ICIO, L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate; PDK1, phosphoinositide-dependent protein kinase 1; PH, plesktrin homology; PI3K, phosphoinositide-3 kinase; PIP2, phosphatidylinositol 3,4-bisphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; PKC, protein kinase C

A supplementary figure showing the results of experiments to determine whether the inhibitors used affected bacterial membrane permeability to antibiotics is available with the online version of this paper.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2007 Society for General Microbiology.